AstraZeneca's total assets for Q1 2026 were $114.02B, a decrease of -0.05% from the previous quarter. GB:AZN total liabilities were $66.63B for the fiscal quarter, a 1.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.